Xuebiao Yao to Middle Aged
This is a "connection" page, showing publications Xuebiao Yao has written about Middle Aged.
Connection Strength
0.244
-
Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009 Oct; 104(7):1009-16.
Score: 0.026
-
Dai B, Kong YY, Ye DW, Ma CG, Zhou XY, Yao XD. Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy. Asian J Androl. 2008 Sep; 10(5):701-9.
Score: 0.025
-
Zhou Z, Yue F, Jin L, Liu X, Zhai TS, Zhang JX, Gu WY, Liu SH, Luo M, Peng B, Yao XD, Ye L. Characteristics and risk differences of different tumor size on localized prostate cancer: A retrospective cohort study in the SEER database. Cancer Med. 2021 04; 10(8):2763-2773.
Score: 0.015
-
Li W, Yang FQ, Sun CM, Huang JH, Zhang HM, Li X, Wang GC, Zhang N, Che JP, Zhang WT, Yan Y, Yao XD, Peng B, Zheng JH, Liu M. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma. Theranostics. 2020; 10(10):4395-4409.
Score: 0.014
-
Zhai TS, Jin L, Hu LT, Kadier A, Zhou Z, Liu X, Liu H, Li S, Lu JY, Yao XD, Ye L. Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy. Urol Oncol. 2020 02; 38(2):37.e1-37.e9.
Score: 0.014
-
Fang C, Guo X, Lv X, Yin R, Lv X, Wang F, Zhao J, Bai Q, Yao X, Chen Y. Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K. J Mol Cell Biol. 2017 12 01; 9(6):504-515.
Score: 0.012
-
Guo X, Lv X, Fang C, Lv X, Wang F, Wang D, Zhao J, Ma Y, Xue Y, Bai Q, Yao X, Chen Y. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. Int J Cancer. 2016 10 15; 139(8):1821-9.
Score: 0.011
-
Zhang QH, Li AM, He SL, Yao XD, Zhu J, Zhang ZW, Sheng ZY, Yao YM. Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury. PLoS One. 2015; 10(6):e0129082.
Score: 0.010
-
Hu YY, Dong WD, Xu YF, Yao XD, Peng B, Liu M, Zheng JH. Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis. Biomed Res Int. 2014; 2014:295651.
Score: 0.010
-
Sun W, Feng Y, Yao XD, Xu YF, Peng B, Liu M, Zheng JH. Urinary angiotensinogen is elevated in patients with nephrolithiasis. Biomed Res Int. 2014; 2014:349602.
Score: 0.009
-
Mehrabi S, Partridge EE, Seffens W, Yao X, Aikhionbare FO. Oxidatively modified proteins in the serous subtype of ovarian carcinoma. Biomed Res Int. 2014; 2014:585083.
Score: 0.009
-
Adams G, Mehrabi S, Vatcharapijarn Y, Iyamu OI, Akwe JA, Grizzle WE, Yao X, Aikhionbare FO. Frequencies of mtDNA mutations in primary tissues of colorectal adenopolyps. Front Biosci (Elite Ed). 2013 06 01; 5(3):809-13.
Score: 0.009
-
Zhou JQ, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Ye DW. [Necessity analysis of bone scan in patients with newly diagnosed prostate cancer]. Zhonghua Yi Xue Za Zhi. 2013 Jan 22; 93(4):248-51.
Score: 0.009
-
Wan FN, Zhu Y, Zhou JQ, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL. [Evaluation of perioperative complications in the elderly with radical prostatectomy]. Zhonghua Wai Ke Za Zhi. 2012 Nov; 50(11):995-8.
Score: 0.008
-
Zhou JQ, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Ye DW. [The building and validation of a model to predict the bone metastases of patients with newly diagnosed prostate cancer]. Zhonghua Wai Ke Za Zhi. 2012 Nov; 50(11):999-1002.
Score: 0.008
-
Zhou JQ, Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ. A nomogram to predict the duration of drainage in patients with penile cancer treated with inguinal lymph node dissection. J Urol. 2012 Jan; 187(1):129-33.
Score: 0.008
-
Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, Lin L, Yao H, Su F, Anderson KS, Liu Q, Ewen ME, Yao X, Song E. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell. 2011 Apr 12; 19(4):541-55.
Score: 0.008
-
Zhang HL, Zhu Y, Wang CF, Yao XD, Zhang SL, Dai B, Shen YJ, Zhu YP, Shi GH, Ye DW. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol. 2011 Jun; 18(6):422-30.
Score: 0.008
-
Mehrabi S, Akwe JA, Adams G, Grizzle W, Yao X, Aikhionbare FO. Analysis of mtDNA sequence variants in colorectal adenomatous polyps. Diagn Pathol. 2010 Oct 07; 5:66.
Score: 0.007
-
Zhu Y, Zhang SL, Ye DW, Yao XD, Dai B, Zhang HL, Shen YJ, Zhu YP, Shi GH, Ma CG. Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis. J Urol. 2009 May; 181(5):2103-8.
Score: 0.007
-
Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. J Urol. 2008 Nov; 180(5):2019-23.
Score: 0.006
-
Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res. 2007 Dec 15; 13(24):7296-304.
Score: 0.006
-
Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun. 2004 Mar 12; 315(3):686-91.
Score: 0.005